Introductory Keynotes: Regulator on "What happened in the last two years in regulatory and HTA landscape"
Chairs: Randi Gron (Novo Nordisk) & Eftychia-Eirini Psarelli (EMA)
- Talk 1 (25min): Kit Roes, EMA & Radboud UMC : Guidances /restructuring / new ways to interact with stakeholders
- Talk 2 (25min): Frank Bretz, Novartis: What happened in the last two years in industry?
- Talk 3 (20min): Anja Schiel, EMA & Norwegian Medicines Agency: Selection of "HTA hot topics" that need discussion in coming months